N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide

C28H29N5O3 — CID 136752683

IUPACN-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide
SMILESCOc1ccc([C@H]2C[C@H](c3ccc(OC)cc3)Nc3nc(NC(=O)CCc4ccccc4)nn32)cc1
InChIInChI=1S/C28H29N5O3/c1-35-22-13-9-20(10-14-22)24-18-25(21-11-15-23(36-2)16-12-21)33-28(29-24)31-27(32-33)30-26(34)17-8-19-6-4-3-5-7-19/h3-7,9-16,24-25H,8,17-18H2,1-2H3,(H2,29,30,31,32,34)/t24-,25-/m1/s1
InChIKeyUPEYXADYXVQUMX-JWQCQUIFSA-N
MW483.57 g/mol
LogP5.01
Rot. Bonds8

About N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide

N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide (PubChem CID 136752683) has the molecular formula C28H29N5O3 and a molecular weight of 483.57 g/mol. Its IUPAC name is N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide.

Molecular Properties

Compound NameN-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide
PubChem CID136752683
Molecular FormulaC28H29N5O3
Molecular Weight483.57 g/mol
Exact Mass483.23
IUPAC NameN-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide
SMILESCOc1ccc([C@H]2C[C@H](c3ccc(OC)cc3)Nc3nc(NC(=O)CCc4ccccc4)nn32)cc1
InChIInChI=1S/C28H29N5O3/c1-35-22-13-9-20(10-14-22)24-18-25(21-11-15-23(36-2)16-12-21)33-28(29-24)31-27(32-33)30-26(34)17-8-19-6-4-3-5-7-19/h3-7,9-16,24-25H,8,17-18H2,1-2H3,(H2,29,30,31,32,34)/t24-,25-/m1/s1
InChIKeyUPEYXADYXVQUMX-JWQCQUIFSA-N
XLogP5.01
TPSA90.30 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500483.57
LogP ≤ 55.01
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide?
The IUPAC name of N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide (CID 136752683) is N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide.
What is the SMILES notation for N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide?
The canonical SMILES for N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide is COc1ccc([C@H]2C[C@H](c3ccc(OC)cc3)Nc3nc(NC(=O)CCc4ccccc4)nn32)cc1.
What is the InChIKey of N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide?
The InChIKey is UPEYXADYXVQUMX-JWQCQUIFSA-N. The full InChI is InChI=1S/C28H29N5O3/c1-35-22-13-9-20(10-14-22)24-18-25(21-11-15-23(36-2)16-12-21)33-28(29-24)31-27(32-33)30-26(34)17-8-19-6-4-3-5-7-19/h3-7,9-16,24-25H,8,17-18H2,1-2H3,(H2,29,30,31,32,34)/t24-,25-/m1/s1.
What are the key properties of N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide?
N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide has a molecular weight of 483.57 g/mol, XLogP of 5.01, 8 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(5R,7R)-5,7-bis(4-methoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-phenylpropanamide is sourced from PubChem (CID 136752683), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).